Young Adult Black Patients With Acute Myeloid Leukemia Patients Have Higher Death Rate
The younger Black patients with acute myeloid leukemia (AML) had “alarmingly high” early death rates within the first 30 days of study enrollment, indicating possible delays in diagnosis and care, according to research results reported in the journal Blood Advances.
New Brain Signal Technique Could Lead to Personalized Medicine in MS
Brain imaging technique may shed light on the clinical-radiological paradox of multiple sclerosis: structural damage in the brain related to the disease does not necessarily predict clinical disability.
Obesity May Be Associated With More Disabling MS
Research has linked obesity to an increased risk of getting multiple sclerosis. This German study examined whether there is a link between obesity and severity of the disease.
Smartphone Tapping Speed New Tool in Assessing MS, Study Finds
A small, preliminary study suggests that multiple sclerosis patients might be monitored based on the speed for their smartphone use.
Machine Learning Predicts MS Mental Health During Stay-at-Home Orders
A Carnegie Mellon researcher and colleagues used data from smartphones and fitness trackers to build machine learning models to predict depression, fatigue, poor sleep quality and worsening multiple sclerosis symptoms.
Kesimpta Cost-Effective MS Treatment, Says Canadian Study
A Novartis-funded analysis gives the Novaritis MS drug the nod based on a model using efficacy and safety data.
Poverty, Bedtime Regularity Play a Role in Hispanic Children’s Sleep
Study looks at the reasons Hispanic children tend to sleep less. For some, lack of a regular bedtime could be the key.
Healthcare Spending May Help Explain the Association MS and Latitude: Study
The link between higher multiple sclerosis rates and distance from the equator has commonly been explained by vitamin D levels. A new analysis from Johns Hopkins researchers suggests the association may also be linked to healthcare spending and the resources needed to diagnose disease.
COVID-19 Vaccination and People with MS: T Cells Boosted, Antibodies Not So Much
Research shows that patients with multiple sclerosis who have been treated with drugs that target CD20 B cells drugs, such as Ocrevus and Rituxan, tend to have a weak antibody response. But cellular immunity and T cells are activated. The results suggest a need for vaccines that boost T cells.
Hodgkin Lymphoma Patients Have Higher Cardiovascular Mortality Risk Than Cancer
For almost all the patients with stage I or stage II disease, the cumulative incidence of CVD mortality exceeded that of classical Hodgkin lymphoma and other cancers, according to research results published in the journal Cancer.
Biosimilar to Tysabri for Relapsing-Remitting MS Is On Its Way
Sandoz has filed an application for a biosimilar to the blockbuster multiple sclerosis drug. It is not clear when it will be on the market.
Digital Therapeutic Shows Promise For MS Fatigue
German company says German healthcare system is covering its digital therapeutic called Elevida, which is based on cognitive behavioral therapy.
Intermittent Fasting, Weight Loss Surgery Have Different Outcomes in MS
Recent research suggests that bariatric surgery could have an unintended consequence of worsening MS.
New Treatments for Difficult-To-Treat Lymphomas Are on Their Way
The FDA has approved two CAR-T therapies and a review of bispecific antibody is underway.
Intervention to Address Financial Toxicity Improves Blood Cancer Survival, Quality of Life
Results show that the mortality risk was cut in half for patients who got help with the financial burden of their care. Quality of life scores also improved.
FDA Places Partial Hold on Clinical Trials of MS, Myasthenia Gravis Drug
Several cases of liver injury have been identified in phase 3 clinical trials of tolebrutinib.
Black Patients With MS at Higher Risk for Uncontrolled Hypertension
Hypertension adversely impacts the multiple sclerosis (MS) disease course and is more common among Black Americans
Studies Find MS Patients Need Early Help for Pain and Anxiety
Screening for depression also should happen quickly to maintain quality of life, two new studies of multiple sclerosis indicate.
Liver Transplants from Drug Overdose Donors Rose As the COVID-19 Pandemic Took Hold
The percentage of livers from donors who died of overdose increased by 26% from a pre-COVID-19 period of January 2019 to February 2020 compared with a pandemic period of May 2020 to June 2021.
Review Links PFAS to Nonalcoholic Fatty Liver Disease
Evaluation of 111 studies showed a link between the endocrine-disrupting chemicals and elevated levels of alanine aminotransferase, a liver enzyme elevated in people with nonalcoholic fatty liver disease.
MS Patients Experienced New Depression, Anxiety During COVID-19
Pharma Exec Details Hepatitis B Progress, New HBV
VBI Vaccines’s PreHevbrio [Hepatitis B Vaccine (Recombinant)], the only approved 3-antigen hepatitis B vaccine for adults, is now commercially available in the U.S. after approval by the FDA late last year.
Alcohol’s Role in Liver Disease Deaths During COVID-19
The overall number of deaths involving alcohol spiked 25.5% to 99,017 between 2019 and 2020.
MS Patients Warmed To Telehealth During the COVID-19 Pandemic
Analysis of answers to online survey shows that telehealth use is high among people with multiple sclerosis (MS) amid the COVID-19 pandemic. Telehealth may be an appealing option for patients with MS who have physical impairments that make traveling to in-person appointments difficult.
New VCU Institute Aims to Transform Treatment of Liver Disease Care
One of the priorities of the new institute at Virginia Commonwealth University’s medical school will be research into nonalcoholic steatohepatitis (NASH) as a key component in the emerging construct of metabolic health, says its leader, Arun J. Sanyal, M.D.
Study Identifies NAFLD-Hypoglycemia Link Among Type 2 Diabetes Patients
Researchers say their results suggest that clinicians should consider nonalcoholic fatty liver disease a risk factor for hypoglycemia among their patients with type 2 diabetes.
MS Patients Respond to Pfizer, Moderna Booster Shots
Antibodies level went after a third dose but the response was weaker among those being treated with fingolimod than among those taking anti-CD20 treatments such as Rituxan.
As Price Pharmacies Pay For Generic Entecavir Plummeted, Out-of-Pocket Expenditures for Patients Increased
Findings reported in JAMA Network Open show that patients with chronic hepatitis B didn’t reap the benefits of price competition as the number of generic suppliers of the antiviral increased from one to 11.
COVID-19-Related Increase in Alcohol Use Could Hike Liver Disease Death Rates
Excessive drinking has increased 21% during the pandemic.
MAFLD Linked to Air Pollution
A study conducted in China shows an association between metabolic-associated fatty liver disease and air pollution.
2 Commerce Drive Cranbury, NJ 08512